WO2002011694A3 - Compositions et formes posologiques en vue d'une application dans la cavite orale dans le cadre du traitement de mycoses - Google Patents

Compositions et formes posologiques en vue d'une application dans la cavite orale dans le cadre du traitement de mycoses Download PDF

Info

Publication number: WO2002011694A3
Authority: WO; WIPO (PCT)
Prior art keywords: application; oral cavity; mykoses; compositions; treatment
Prior art date: 2000-08-03

Application number

PCT/EP2001/008978

Other languages

English (en)

Other versions

WO2002011694A2 (fr

Inventor

Joerg Rosenberg

Gunther Berndl

Joerg Neumann

Joerg Breitenbach

Original Assignee

Knoll Gmbh

Joerg Rosenberg

Gunther Berndl

Joerg Neumann

Joerg Breitenbach

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-08-03

Filing date

2001-08-02

Publication date

2002-04-25

2001-08-02 Application filed by Knoll Gmbh, Joerg Rosenberg, Gunther Berndl, Joerg Neumann, Joerg Breitenbach filed Critical Knoll Gmbh

2001-08-02 Priority to AU2001295448A priority Critical patent/AU2001295448A1/en

2001-08-02 Priority to AT01976055T priority patent/ATE262893T1/de

2001-08-02 Priority to CA2417709A priority patent/CA2417709C/fr

2001-08-02 Priority to BR0112847-7A priority patent/BR0112847A/pt

2001-08-02 Priority to US10/343,019 priority patent/US20040029892A1/en

2001-08-02 Priority to EP01976055A priority patent/EP1305010B1/fr

2001-08-02 Priority to JP2002517032A priority patent/JP2004505905A/ja

2001-08-02 Priority to DE60102590T priority patent/DE60102590T2/de

2002-02-14 Publication of WO2002011694A2 publication Critical patent/WO2002011694A2/fr

2002-04-25 Publication of WO2002011694A3 publication Critical patent/WO2002011694A3/fr

Links

210000000214 mouth Anatomy 0.000 title abstract 2
206010017533 Fungal infection Diseases 0.000 title 1
239000002552 dosage form Substances 0.000 title 1
239000000203 mixture Substances 0.000 title 1
239000004480 active ingredient Substances 0.000 abstract 1
239000011159 matrix material Substances 0.000 abstract 1
239000007909 solid dosage form Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Epidemiology (AREA)
Nutrition Science (AREA)
Physiology (AREA)
Zoology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Cosmetics (AREA)

PCT/EP2001/008978 2000-08-03 2001-08-02 Compositions et formes posologiques en vue d'une application dans la cavite orale dans le cadre du traitement de mycoses WO2002011694A2 (fr)

Priority Applications (8)

Application Number	Priority Date	Filing Date	Title
AU2001295448A AU2001295448A1 (en)	2000-08-03	2001-08-02	Compositions and dosage forms for application in the oral cavity in the treatment of mykoses
AT01976055T ATE262893T1 (de)	2000-08-03	2001-08-02	Darreichungsformen zur behandlung von oralen mykosen
CA2417709A CA2417709C (fr)	2000-08-03	2001-08-02	Compositions et formes posologiques en vue d'une application dans la cavite orale dans le cadre du traitement de mycoses
BR0112847-7A BR0112847A (pt)	2000-08-03	2001-08-02	Uso de uma forma de dosagem sólida
US10/343,019 US20040029892A1 (en)	2000-08-03	2001-08-02	Compositions and dosage forms for application in the oral cavity in the treatment of mykoses
EP01976055A EP1305010B1 (fr)	2000-08-03	2001-08-02	Formes posologiques pour le traitement de mycoses orales
JP2002517032A JP2004505905A (ja)	2000-08-03	2001-08-02	真菌症の治療における口腔内に適用する組成物および剤形
DE60102590T DE60102590T2 (de)	2000-08-03	2001-08-02	Darreichungsformen zur behandlung von oralen mykosen

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE10038571.0		2000-08-03
DE10038571A DE10038571A1 (de)	2000-08-03	2000-08-03	Zusammensetzungen und Dosierungsformen zur Anwendung in der Mundhöhle bei der Bhandlung von Mykosen

Publications (2)

Publication Number	Publication Date
WO2002011694A2 WO2002011694A2 (fr)	2002-02-14
WO2002011694A3 true WO2002011694A3 (fr)	2002-04-25

Family

ID=7651652

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PCT/EP2001/008978 WO2002011694A2 (fr)	2000-08-03	2001-08-02	Compositions et formes posologiques en vue d'une application dans la cavite orale dans le cadre du traitement de mycoses

Country Status (13)

Country	Link
US (1)	US20040029892A1 (fr)
EP (1)	EP1305010B1 (fr)
JP (1)	JP2004505905A (fr)
CN (1)	CN1274297C (fr)
AT (1)	ATE262893T1 (fr)
AU (1)	AU2001295448A1 (fr)
BR (1)	BR0112847A (fr)
CA (1)	CA2417709C (fr)
DE (2)	DE10038571A1 (fr)
ES (1)	ES2218456T3 (fr)
RU (1)	RU2003105812A (fr)
WO (1)	WO2002011694A2 (fr)
ZA (1)	ZA200301672B (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7364752B1 (en)	1999-11-12	2008-04-29	Abbott Laboratories	Solid dispersion pharamaceutical formulations
WO2001034119A2 (fr) *	1999-11-12	2001-05-17	Abbott Laboratories	Inhibiteurs de cristallisation dans une dispersion solide
DE10026698A1 (de) *	2000-05-30	2001-12-06	Basf Ag	Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
EP2338475A3 (fr) *	2001-11-05	2012-08-08	Orahealth Corporation	Traitement d'aphtes au moyen de patchs permettant de guérir et de soulager la douleur rapidement
JP2005538973A (ja) *	2002-07-04	2005-12-22	ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ	異なる２種類のポリマーマトリックスを含んで成る固体分散体
DE10332160A1 (de)	2003-07-15	2005-02-03	Röhm GmbH & Co. KG	Multipartikuläre Arzneiform, enthaltend mucoadhaesiv formulierte Peptid- oder Protein-Wirkstoffe, sowie ein Verfahren zur Herstellung der Arzneiform
US8025899B2 (en)	2003-08-28	2011-09-27	Abbott Laboratories	Solid pharmaceutical dosage form
US8377952B2 (en) *	2003-08-28	2013-02-19	Abbott Laboratories	Solid pharmaceutical dosage formulation
JP2007517016A (ja)	2003-12-31	2007-06-28	ファイザー・プロダクツ・インク	低溶解性薬剤及びポロキサマーの固体組成物
CN1294912C (zh) *	2004-03-01	2007-01-17	上海医药工业研究院	伊曲康唑盐酸盐组合物及其冻干粉针
JP2006096728A (ja) *	2004-09-30	2006-04-13	Kobayashi Pharmaceut Co Ltd	口腔内定着型固形製剤
US20070048369A1 (en) *	2005-08-26	2007-03-01	National Starch And Chemical Investment Holding Corporation	Mucosal delivery tablet
EP2037895A4 (fr) *	2006-05-23	2009-12-02	Orahealth Corp	Trochisques à base de xilitol et leurs procédés d'utilisation
CN101108172B (zh) *	2006-07-17	2010-10-06	天津药物研究院	一种口腔粘贴片及其制备方法
GB0703998D0 (en)	2007-03-01	2007-04-11	Glaxo Group Ltd	Novel salt
BR112013008737A2 (pt) *	2010-10-14	2015-09-01	Abbott Gmbh & Co Kg	Formulação de dispersão sólida de curcuminóide
FR2972327B1 (fr) *	2011-03-11	2017-08-11	Laboratoires Le Stum	Composition nutraceutique mucoadhesive comprenant une association d'antioxydants

Citations (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0240906A2 (fr) *	1986-04-11	1987-10-14	BASF Aktiengesellschaft	Procédé pour pastiller en continu
EP0250187A2 (fr) *	1986-06-16	1987-12-23	JOHNSON & JOHNSON CONSUMER PRODUCTS, INC.	Film bioadhésif extrudé pour la libération intra-orale d'un médicament et procédé
WO1993018757A1 (fr) *	1992-03-17	1993-09-30	Pfizer Inc.	Procede de fabrication concernant des comprimes poreux
US5431915A (en) *	1993-12-20	1995-07-11	Harvey; Bryce M.	Frozen oral medication delivery system and method
US5578315A (en) *	1993-12-01	1996-11-26	Rutgers, The State University Of New Jersey	Mucosal adhesive device for long-acting delivery of pharmaceutical combinations in oral cavity
DE19539359A1 (de) *	1995-10-23	1997-04-24	Knoll Ag	Formbandkalander
WO1997044014A1 (fr) *	1996-05-20	1997-11-27	Janssen Pharmaceutica N.V.	Compositions antifongiques avec biodisponibilite amelioree
EP0864326A2 (fr) *	1997-03-12	1998-09-16	Knoll Ag	Préparation multiphasique comprenant un agent actif

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH0920680A (ja) *	1995-01-24	1997-01-21	Hideyo Yamaguchi	抗真菌剤

2000
- 2000-08-03 DE DE10038571A patent/DE10038571A1/de not_active Withdrawn
2001
- 2001-08-02 BR BR0112847-7A patent/BR0112847A/pt not_active Application Discontinuation
- 2001-08-02 CA CA2417709A patent/CA2417709C/fr not_active Expired - Lifetime
- 2001-08-02 RU RU2003105812/15A patent/RU2003105812A/ru not_active Application Discontinuation
- 2001-08-02 WO PCT/EP2001/008978 patent/WO2002011694A2/fr active IP Right Grant
- 2001-08-02 US US10/343,019 patent/US20040029892A1/en not_active Abandoned
- 2001-08-02 CN CNB018135765A patent/CN1274297C/zh not_active Expired - Lifetime
- 2001-08-02 AU AU2001295448A patent/AU2001295448A1/en not_active Abandoned
- 2001-08-02 ES ES01976055T patent/ES2218456T3/es not_active Expired - Lifetime
- 2001-08-02 DE DE60102590T patent/DE60102590T2/de not_active Expired - Lifetime
- 2001-08-02 JP JP2002517032A patent/JP2004505905A/ja active Pending
- 2001-08-02 AT AT01976055T patent/ATE262893T1/de not_active IP Right Cessation
- 2001-08-02 EP EP01976055A patent/EP1305010B1/fr not_active Expired - Lifetime
2003
- 2003-02-28 ZA ZA200301672A patent/ZA200301672B/en unknown

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0240906A2 (fr) *	1986-04-11	1987-10-14	BASF Aktiengesellschaft	Procédé pour pastiller en continu
EP0250187A2 (fr) *	1986-06-16	1987-12-23	JOHNSON & JOHNSON CONSUMER PRODUCTS, INC.	Film bioadhésif extrudé pour la libération intra-orale d'un médicament et procédé
WO1993018757A1 (fr) *	1992-03-17	1993-09-30	Pfizer Inc.	Procede de fabrication concernant des comprimes poreux
US5578315A (en) *	1993-12-01	1996-11-26	Rutgers, The State University Of New Jersey	Mucosal adhesive device for long-acting delivery of pharmaceutical combinations in oral cavity
US5431915A (en) *	1993-12-20	1995-07-11	Harvey; Bryce M.	Frozen oral medication delivery system and method
DE19539359A1 (de) *	1995-10-23	1997-04-24	Knoll Ag	Formbandkalander
WO1997044014A1 (fr) *	1996-05-20	1997-11-27	Janssen Pharmaceutica N.V.	Compositions antifongiques avec biodisponibilite amelioree
EP0864326A2 (fr) *	1997-03-12	1998-09-16	Knoll Ag	Préparation multiphasique comprenant un agent actif

Also Published As

Publication number	Publication date
WO2002011694A2 (fr)	2002-02-14
CN1274297C (zh)	2006-09-13
DE60102590D1 (de)	2004-05-06
DE60102590T2 (de)	2005-04-21
US20040029892A1 (en)	2004-02-12
CA2417709C (fr)	2010-05-11
AU2001295448A1 (en)	2002-02-18
EP1305010B1 (fr)	2004-03-31
EP1305010A2 (fr)	2003-05-02
ES2218456T3 (es)	2004-11-16
DE10038571A1 (de)	2002-02-14
ZA200301672B (en)	2004-03-01
BR0112847A (pt)	2003-06-24
ATE262893T1 (de)	2004-04-15
RU2003105812A (ru)	2004-09-27
CA2417709A1 (fr)	2002-02-14
CN1444473A (zh)	2003-09-24
JP2004505905A (ja)	2004-02-26

Legal Events

Date	Code	Title	Description
2002-02-14	AK	Designated states	Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW
2002-02-14	AL	Designated countries for regional patents	Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG
2002-04-10	121	Ep: the epo has been informed by wipo that ep was designated in this application
2002-05-10	DFPE	Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
2003-01-29	WWE	Wipo information: entry into national phase	Ref document number: 018135765 Country of ref document: CN
2003-01-30	WWE	Wipo information: entry into national phase	Ref document number: 2001976055 Country of ref document: EP Ref document number: 2417709 Country of ref document: CA
2003-01-31	WWE	Wipo information: entry into national phase	Ref document number: 2002517032 Country of ref document: JP Ref document number: 2001295448 Country of ref document: AU
2003-02-28	WWE	Wipo information: entry into national phase	Ref document number: 2003/01672 Country of ref document: ZA Ref document number: 200301672 Country of ref document: ZA
2003-03-03	ENP	Entry into the national phase	Ref document number: 2003105812 Country of ref document: RU Kind code of ref document: A Ref country code: RU Ref document number: RU A
2003-05-02	WWP	Wipo information: published in national office	Ref document number: 2001976055 Country of ref document: EP
2003-05-20	WWE	Wipo information: entry into national phase	Ref document number: 10343019 Country of ref document: US
2003-06-12	REG	Reference to national code	Ref country code: DE Ref legal event code: 8642
2004-03-31	WWG	Wipo information: grant in national office	Ref document number: 2001976055 Country of ref document: EP

Publication	Publication Date	Title
MX2007015480A (es)	2008-04-29	Formulaciones de dosificacion solida de medicamentos narcoticos que tienen adsorcion bucal mejorada.
WO2002011694A3 (fr)	2002-04-25	Compositions et formes posologiques en vue d'une application dans la cavite orale dans le cadre du traitement de mycoses
HUP0302319A3 (en)	2013-04-29	Pharmaceutical composition for oral administration of active ingredient
IL219820A0 (en)	2012-06-28	Hydrophilic controlled release formulation comprising pregelatinized starch for controlled release of an active component
TW200505498A (en)	2005-02-16	Sugar-free oral transmucosal solid dosage forms and uses thereof
YU33099A (sh)	2002-06-19	Farmaceutska smesa za poboljšanje erektilne disfunkcije kod muškaraca
EP1566174A3 (fr)	2007-04-04	Forme de dosage orale très fondante
AP1954A (en)	2009-02-10	Controlled release compositions comprising nimesulide.
MY118371A (en)	2004-10-30	Tetrahydrolipstatin containing compositions
IL165786A0 (en)	2006-01-15	Ibuprofen suspension
AP2003002763A0 (en)	2003-03-31	Controlled release formulations for oral administration
ATE287264T1 (de)	2005-02-15	Oral anzuwendende buprenorphinhaltige arzneimittel
MXPA06000332A (es)	2006-03-30	Nueva composicion farmaceutica solida que comprende amisulprida.
MY130445A (en)	2007-06-29	Novel formulations of alpha-2, 4-disulfophenyl-n-tert-butylnitrone
MY141008A (en)	2010-02-12	Oral formulations of deoxypeganine and their uses
PL1499278T3 (pl)	2005-09-30	Farmaceutyczna postać użytkowa o natychmiastowym uwalnianiu zawierająca polimorficzny tibolon
ECSP982396A (es)	1999-01-12	Composiciones que contienen tetrahidrolipstatina
MY145885A (en)	2012-05-15	Controlled release formulations for oral administration